Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-24 @ 9:30 PM
NCT ID:
NCT05468632
Eligibility Criteria:
Inclusion Criteria:
* Male or female, age above or equal to 18 years at the time of once weekly (OW) semaglutide initiation.
* The decision to initiate treatment with commercially available OW semaglutide has been made by the participant and the treating physician before and independently from the decision to include the participant in this study.
* Adult participants with type 2 diabetes (T2D) initiated with OW semaglutide at least 30 +- 4 weeks prior to data collection.
* Participants should have baseline glycated haemoglobin (HbA1c) measurement and at least one HbA1c measurement after baseline. For baseline HbA1c measurement, the most recent value less than 12 weeks prior to OW semaglutide initiation will be used.
Exclusion Criteria:
* Previous participation in this study.
* Prior use of GLP-1 within last one year.
* Participants with type-1 diabetes and gestational diabetes.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05468632
Study Brief:
Protocol Section:
NCT05468632